chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Ageusia, Body temperature, Fatigue, Headache
Clinical narrative: I lost taste for a day (1st dose); a lot of fatigue (1st dose); headache (1st dose); This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)), AGEUSIA (I lost taste for a day (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-May-2021, the patient experienced FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ). On an unknown date, the patient experienced AGEUSIA (I lost taste for a day (1st dose)). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. On 10-May-2021, FATIGUE (a lot of fatigue (1st dose)), HEADACHE (headache (1st dose)) and BODY TEMPERATURE INCREASED (temperature that lasted two days ) had resolved. At the time of the report, AGEUSIA (I lost taste for a day (1st dose)) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 08-May-2021, Body temperature: abnormal (abnormal) temperature that lasted two days, Recovered on 10/May/2021.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication reported.   This case was linked to MOD-2021-220933 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Headache
Clinical narrative: Getting headaches from the vaccine (second dose); This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Getting headaches from the vaccine (second dose)) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced HEADACHE (Getting headaches from the vaccine (second dose)). At the time of the report, HEADACHE (Getting headaches from the vaccine (second dose)) outcome was unknown.            No concomitant medication were reported. No treatment information was reported.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Dehydration, Nausea, Vomiting
Clinical narrative: Dehydration; Nausea; Throws up everything he eats even water; This spontaneous case was reported by a consumer and describes the occurrence of DEHYDRATION (Dehydration), NAUSEA (Nausea) and VOMITING (Throws up everything he eats even water) in a 55-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 03621A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 05-Jun-2021, the patient experienced DEHYDRATION (Dehydration), NAUSEA (Nausea) and VOMITING (Throws up everything he eats even water). At the time of the report, DEHYDRATION (Dehydration), NAUSEA (Nausea) and VOMITING (Throws up everything he eats even water) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.  On 12 Jun 2021, the patient went to the ER (Emergency Room) and received an unknown IV (intravenous) fluid.
Sex: U
Vaccine: COVID19
Symptoms: Dry mouth, Nausea, Thirst
Clinical narrative: Dry mouth; Thirst; Morning nausea/Evening nausea; This spontaneous case was reported by a consumer and describes the occurrence of DRY MOUTH (Dry mouth), THIRST (Thirst) and NAUSEA (Morning nausea/Evening nausea) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DRY MOUTH (Dry mouth), THIRST (Thirst) and NAUSEA (Morning nausea/Evening nausea). At the time of the report, DRY MOUTH (Dry mouth), THIRST (Thirst) and NAUSEA (Morning nausea/Evening nausea) had not resolved.            No concomitant medications were mentioned.  The patient reported receiving the vaccine 5 days ago, exact date unknown.  No treatment details were reported.
Sex: U
Vaccine: COVID19
Symptoms: Chest pain
Clinical narrative: chest pains; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (chest pains) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (chest pains). At the time of the report, CHEST PAIN (chest pains) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant medications were not reported.  Treatment information was not provided.
Age: 24.0
Sex: F
Vaccine: COVID19
Symptoms: Fatigue, Headache, Myalgia, Oropharyngeal pain, Vomiting
Clinical narrative: Throat pain; Very very tired; Vomits; body aches/pain in the whole body; Headache; This spontaneous case was reported by a consumer and describes the occurrence of OROPHARYNGEAL PAIN (Throat pain), VOMITING (Vomits), MYALGIA (body aches/pain in the whole body), HEADACHE (headache) and FATIGUE (Very very tired ) in a 24-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 041B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 11-Jun-2021, the patient experienced VOMITING (Vomits), MYALGIA (body aches/pain in the whole body) and HEADACHE (headache). On 13-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (Throat pain) and FATIGUE (Very very tired ). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at a dose of 1 dosage form. At the time of the report, OROPHARYNGEAL PAIN (Throat pain), VOMITING (Vomits), MYALGIA (body aches/pain in the whole body), HEADACHE (headache) and FATIGUE (Very very tired ) outcome was unknown.            The patient doesn't take any concomitant medication.   This case was linked to MOD-2021-220918 (Patient Link).
Sex: U
Vaccine: COVID19
Symptoms: Injection site pain, Injection site swelling
Clinical narrative: hurting with a swollen knot; swollen knot; This spontaneous case was reported by a consumer and describes the occurrence of INJECTION SITE PAIN (hurting with a swollen knot) and INJECTION SITE SWELLING (swollen knot) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 2 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INJECTION SITE PAIN (hurting with a swollen knot) and INJECTION SITE SWELLING (swollen knot). At the time of the report, INJECTION SITE PAIN (hurting with a swollen knot) and INJECTION SITE SWELLING (swollen knot) had not resolved.            The patient had the events after second dose.  Treatment medication was not provided
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Blood pressure measurement, Hypotension, Suspected COVID-19
Clinical narrative: felt like having COVID again after both doses; Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40; This spontaneous case was reported by a consumer and describes the occurrence of SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in October 2020, Pneumonia in October 2020 and Blood pressure high (Before both doses of the vaccine, she had high blood pressure). Concomitant products included LOSARTAN for Blood pressure abnormal, ZOLPIDEM TARTRATE (AMBIEN) for Sleeplessness.    On 13-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40). At the time of the report, SUSPECTED COVID-19 (felt like having COVID again after both doses) and HYPOTENSION (Since the first dose, she finds her blood pressure is low and sometimes plummets to about 70/40) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In 2021, Blood pressure measurement: 70/40 (Low) low and sometimes plummets to about 70/40..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication include muscle relaxer and pain medication.  Dose adjustment conducted in blood pressure medication.   This case was linked to MOD-2021-220989 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 08-Jul-2021: Follow up was received on 8-JUL-2021: contains Non significant information
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: got my first dose eight weeks ago/ it's been two months; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (got my first dose eight weeks ago/ it's been two months) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (got my first dose eight weeks ago/ it's been two months). At the time of the report, PRODUCT DOSE OMISSION ISSUE (got my first dose eight weeks ago/ it's been two months) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported No treatment drugs were reported
Sex: U
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: Muscles have been aching; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Muscles have been aching) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced MYALGIA (Muscles have been aching). At the time of the report, MYALGIA (Muscles have been aching) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
Sex: U
Vaccine: COVID19
Symptoms: Lymphadenopathy
Clinical narrative: swollen lymph nodes; This spontaneous case was reported by a patient and describes the occurrence of LYMPHADENOPATHY (swollen lymph nodes) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On 07-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, the patient experienced LYMPHADENOPATHY (swollen lymph nodes). At the time of the report, LYMPHADENOPATHY (swollen lymph nodes) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication use was provided by the reporter.  No treatment of events was reported.
Age: 58.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Feeling cold, Hyperhidrosis, Influenza like illness, Nasopharyngitis
Clinical narrative: Flu like symptoms; sweating; freezing; cold; chills; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), FEELING COLD (freezing), NASOPHARYNGITIS (cold) and CHILLS (chills) in a 58-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included POTASSIUM and VITAMINS NOS for an unknown indication.    In November 2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), FEELING COLD (freezing), NASOPHARYNGITIS (cold) and CHILLS (chills). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms), HYPERHIDROSIS (sweating), FEELING COLD (freezing), NASOPHARYNGITIS (cold) and CHILLS (chills) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment information was not provided.   This case was linked to MOD-2021-220638 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Had a reaction to the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Had a reaction to the vaccine) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Had a reaction to the vaccine). At the time of the report, VACCINATION COMPLICATION (Had a reaction to the vaccine) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No medical history and concomitant medication use was provided by the reporter.  No treatment of events was reported.   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow up received and contact information updated.
Age: 53.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Malaise, Somnolence
Clinical narrative: feeling knocked down /sleep in bed/chair; not feel good; This spontaneous case was reported by a consumer and describes the occurrence of SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good) in a 53-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 005C21A and 017B21A) for COVID-19 vaccination.     The patient's past medical history included Pacemaker insertion (cardiac) (Patient had a pacemaker in his body at the time of the report.) and Defibrillator/pacemaker insertion (Patient had defibrillator in his body at the time of the report.). Concurrent medical conditions included AFib (Heart function is only 35 percent.). Concomitant products included METOPROLOL, ALLOPURINOL, AMIODARONE HYDROCHLORIDE (AMIODARONE HCL), DIGOXIN, PAROXETINE HYDROCHLORIDE (PAROXETINE HCL), WARFARIN SODIUM and BUMETANIDE for an unknown indication.   On 21-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-May-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good). At the time of the report, SOMNOLENCE (feeling knocked down /sleep in bed/chair) and MALAISE (not feel good) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 14-Jun-2021, Blood test: normal (normal) Blood work was done from hospital and it was normal..     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment of events was reported.
Sex: M
Vaccine: COVID19
Symptoms: Diarrhoea, Pyrexia, Vomiting
Clinical narrative: Diarrhea; throwing up; Small fever; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 13-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Jun-2021, the patient experienced DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever). At the time of the report, DIARRHOEA (Diarrhea), VOMITING (throwing up) and PYREXIA (Small fever) outcome was unknown.            No concomitant medications were reported.   No treatment information was provided.
Age: 59.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Hypoaesthesia, Pain in extremity, Vaccination complication
Clinical narrative: singificant loss of strength to the right arm with lot of pain in the elbow area; Weakness; Numbness; Having issues from the vaccine; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Having issues from the vaccine), PAIN IN EXTREMITY (singificant loss of strength to the right arm with lot of pain in the elbow area), ASTHENIA (Weakness) and HYPOAESTHESIA (Numbness) in a 59-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced VACCINATION COMPLICATION (Having issues from the vaccine). On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (singificant loss of strength to the right arm with lot of pain in the elbow area), ASTHENIA (Weakness) and HYPOAESTHESIA (Numbness). At the time of the report, VACCINATION COMPLICATION (Having issues from the vaccine), PAIN IN EXTREMITY (singificant loss of strength to the right arm with lot of pain in the elbow area), ASTHENIA (Weakness) and HYPOAESTHESIA (Numbness) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Most recent FOLLOW-UP information incorporated above includes: On 04-Aug-2021: Follow-up received,Primary reporter's address and vaccine Facility details were updated. Patient's DOB, height and weight, Batch/Lot No. were added. Events: weakness to right arm elbowto hand, numbness to left arm, from shoulder to fingers left side were added.
Sex: F
Vaccine: COVID19
Symptoms: Breast induration, Vaccination complication
Clinical narrative: NOW I AM FELLING A LITTLE SOMETHING IN BRERST, I GOT A FELLING OF SOME KIND OF HARD SPOT ON MY LEFT BREST; I GOT A SIDE SFFECT FROM BOTH SHOTS BACK IN FEB; This spontaneous case was reported by a consumer and describes the occurrence of BREAST INDURATION (NOW I AM FELLING A LITTLE SOMETHING IN BRERST, I GOT A FELLING OF SOME KIND OF HARD SPOT ON MY LEFT BREST) and VACCINATION COMPLICATION (I GOT A SIDE SFFECT FROM BOTH SHOTS BACK IN FEB) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BREAST INDURATION (NOW I AM FELLING A LITTLE SOMETHING IN BRERST, I GOT A FELLING OF SOME KIND OF HARD SPOT ON MY LEFT BREST) and VACCINATION COMPLICATION (I GOT A SIDE SFFECT FROM BOTH SHOTS BACK IN FEB). At the time of the report, BREAST INDURATION (NOW I AM FELLING A LITTLE SOMETHING IN BRERST, I GOT A FELLING OF SOME KIND OF HARD SPOT ON MY LEFT BREST) and VACCINATION COMPLICATION (I GOT A SIDE SFFECT FROM BOTH SHOTS BACK IN FEB) outcome was unknown.            No medical information was provided by the reporter.  No treatment information was reported.
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Alopecia
Clinical narrative: Having tons of hair loss; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jun-2021 and was forwarded to Moderna on 14-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ALOPECIA (Having tons of hair loss) in a 53-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 036C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jun-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Jun-2021, the patient experienced ALOPECIA (Having tons of hair loss). At the time of the report, ALOPECIA (Having tons of hair loss) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No relevant concomitant medications were reported. No treatment was received.  Reporter reported hair loss is continuing, states she looks like "a balding man".   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: FU received on 05-08-2021 with Event outcome continuing and No new information.
Sex: M
Vaccine: COVID19
Symptoms: Discomfort, Electric shock sensation, Hypoaesthesia, Insomnia, Paraesthesia
Clinical narrative: pain and discomfort is a 3.5 out of 10; electric shock going down his arms and legs; numbness and tingling in left arm and leg/"little back numbness and tingling in right arm and leg"; numbness and tingling in left arm and leg/ "little back numbness and tingling in right arm and leg"; could not sleep; This spontaneous case was reported by a consumer and describes the occurrence of HYPOAESTHESIA (numbness and tingling in left arm and leg/"little back numbness and tingling in right arm and leg"), PARAESTHESIA (numbness and tingling in left arm and leg/ "little back numbness and tingling in right arm and leg"), INSOMNIA (could not sleep), DISCOMFORT (pain and discomfort is a 3.5 out of 10) and ELECTRIC SHOCK SENSATION (electric shock going down his arms and legs) in a 69-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 020B21A) for COVID-19 vaccination.     Concomitant products included LISINOPRIL and ATORVASTATIN for an unknown indication.   On 03-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 31-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to at an unspecified dose. On 10-Mar-2021, the patient experienced HYPOAESTHESIA (numbness and tingling in left arm and leg/"little back numbness and tingling in right arm and leg"), PARAESTHESIA (numbness and tingling in left arm and leg/ "little back numbness and tingling in right arm and leg") and INSOMNIA (could not sleep). On an unknown date, the patient experienced DISCOMFORT (pain and discomfort is a 3.5 out of 10) and ELECTRIC SHOCK SENSATION (electric shock going down his arms and legs). At the time of the report, HYPOAESTHESIA (numbness and tingling in left arm and leg/"little back numbness and tingling in right arm and leg"), PARAESTHESIA (numbness and tingling in left arm and leg/ "little back numbness and tingling in right arm and leg"), INSOMNIA (could not sleep), DISCOMFORT (pain and discomfort is a 3.5 out of 10) and ELECTRIC SHOCK SENSATION (electric shock going down his arms and legs) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) dosing remained unchanged.       No treatment information was provided.   This case was linked to MOD-2021-220937 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 07-Jul-2021: Follow up significant. Event information updated.
Age: 25.0
Sex: M
Vaccine: COVID19
Symptoms: Chest pain, Dyspnoea, Headache, Nausea
Clinical narrative: pain in the chest that moves towards the lung on the left side; shortness of breath; strong head ache; nausea; This spontaneous case was reported by a consumer and describes the occurrence of CHEST PAIN (pain in the chest that moves towards the lung on the left side), DYSPNOEA (shortness of breath), HEADACHE (strong head ache) and NAUSEA (nausea) in a 25-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced CHEST PAIN (pain in the chest that moves towards the lung on the left side), DYSPNOEA (shortness of breath), HEADACHE (strong head ache) and NAUSEA (nausea). The patient was treated with IBUPROFEN for Headache, at an unspecified dose and frequency. At the time of the report, CHEST PAIN (pain in the chest that moves towards the lung on the left side), DYSPNOEA (shortness of breath), HEADACHE (strong head ache) and NAUSEA (nausea) outcome was unknown.            No concomitant medications information was provided.  Action taken with mRNA-1273 in response to the event was not applicable.
Age: 19.0
Sex: M
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Patient outside the 42 day window; This spontaneous case was reported by a pharmacist and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Patient outside the 42 day window) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Patient outside the 42 day window). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Patient outside the 42 day window) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter..
Sex: U
Vaccine: COVID19
Symptoms: Erythema, Pruritus
Clinical narrative: arm  red; Itching all over; This case was received via an unknown source (no reference has been entered for a health authority or license partner) on 14-Jun-2021 and was forwarded to Moderna on 14-Jun-2021.    This spontaneous case was reported by a consumer and describes the occurrence of ERYTHEMA (arm  red) and PRURITUS (Itching all over) in a  patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced ERYTHEMA (arm  red) and PRURITUS (Itching all over). At the time of the report, ERYTHEMA (arm  red) and PRURITUS (Itching all over) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.   No treatment information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Fatigue, Muscular weakness
Clinical narrative: Weakness in my muscles, particularly my legs; Fatigue; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of MUSCULAR WEAKNESS (Weakness in my muscles, particularly my legs) and FATIGUE (Fatigue) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 09-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 09-Apr-2021, the patient experienced MUSCULAR WEAKNESS (Weakness in my muscles, particularly my legs) and FATIGUE (Fatigue). At the time of the report, MUSCULAR WEAKNESS (Weakness in my muscles, particularly my legs) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       The concomitant medications were not reported.  The treatment information was not provided. Patient said that Prior to getting the vaccine, Patient was walking 2 miles a day, doing 100 squats each day, 30 sit ups, pushups, wall.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity
Clinical narrative: Sore arm; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm). At the time of the report, PAIN IN EXTREMITY (Sore arm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication information was not provided.  Treatment medicines was not provided.   This case was linked to MOD-2021-220974.
Sex: U
Vaccine: COVID19
Symptoms: Cough, Pyrexia
Clinical narrative: cough after second dose; fever after second dose; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of COUGH (cough after second dose) and PYREXIA (fever after second dose) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced COUGH (cough after second dose) and PYREXIA (fever after second dose). At the time of the report, COUGH (cough after second dose) and PYREXIA (fever after second dose) outcome was unknown.            Concomitant medication was not provided.  Treatment information was not provided.  Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) in response to the event was not applicable.   Reporter did not allow further contact
Sex: U
Vaccine: COVID19
Symptoms: Abdominal pain, Diarrhoea, Flatulence
Clinical narrative: diarrhea; gas; severe abdominal cramping; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL PAIN (severe abdominal cramping), DIARRHOEA (diarrhea) and FLATULENCE (gas) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    In January 2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. In January 2021, the patient experienced ABDOMINAL PAIN (severe abdominal cramping). On an unknown date, the patient experienced DIARRHOEA (diarrhea) and FLATULENCE (gas). At the time of the report, ABDOMINAL PAIN (severe abdominal cramping), DIARRHOEA (diarrhea) and FLATULENCE (gas) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.  The patient reported severe abdominal cramping, diarrhea and gas with grains and dairy. No information regarding corrective treatment was reported by the patient.
Age: 70.0
Sex: M
Vaccine: COVID19
Symptoms: Erythema, Pain in extremity, Swelling
Clinical narrative: Pain on the injection arm; Swelling; Redness; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain on the injection arm), SWELLING (Swelling) and ERYTHEMA (Redness) in a 70-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 026C21A) for COVID-19 vaccination.     Concurrent medical conditions included Arthritis. Concomitant products included PREDNISONE for Arthritis, ALFUZOSIN and CARVEDILOL for an unknown indication.    On 14-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In May 2021, the patient experienced PAIN IN EXTREMITY (Pain on the injection arm), SWELLING (Swelling) and ERYTHEMA (Redness). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (Pain on the injection arm), SWELLING (Swelling) and ERYTHEMA (Redness) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient was not sure about receiving the scheduled second dose on 15-Jun-2021 due to his reaction.
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Vaginal haemorrhage
Clinical narrative: vaginal bleeding; This spontaneous case was reported by a consumer and describes the occurrence of VAGINAL HAEMORRHAGE (vaginal bleeding) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006B21A and 031M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. In March 2021, the patient experienced VAGINAL HAEMORRHAGE (vaginal bleeding). In April 2021, VAGINAL HAEMORRHAGE (vaginal bleeding) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route), the reporter did not provide any causality assessments.   Action taken with mRNA-1273 in response to the events was not applicable.  No concomitant medications were reported. No treatment medications were reported.
Age: 38.0
Sex: M
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: received the second dose of the Moderna Covid-19 Vaccine 21 days after receiving the first dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose of the Moderna Covid-19 Vaccine 21 days after receiving the first dose) in a 38-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 033B21A and 033B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 24-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 14-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 14-Jun-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose of the Moderna Covid-19 Vaccine 21 days after receiving the first dose). On 14-Jun-2021, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (received the second dose of the Moderna Covid-19 Vaccine 21 days after receiving the first dose) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported by the reporter.
Sex: U
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: Late getting my second shot the Moderna vacinne; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT DOSE OMISSION ISSUE (Late getting my second shot the Moderna vacinne) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PRODUCT DOSE OMISSION ISSUE (Late getting my second shot the Moderna vacinne). At the time of the report, PRODUCT DOSE OMISSION ISSUE (Late getting my second shot the Moderna vacinne) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported by the reporter.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Bronchitis, Nasopharyngitis, Rhinorrhoea
Clinical narrative: Bronchitis twice; Four colds; Nose has been running constantly; This spontaneous case was reported by a consumer and describes the occurrence of BRONCHITIS (Bronchitis twice), NASOPHARYNGITIS (Four colds) and RHINORRHOEA (Nose has been running constantly) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011J20A and 029K20A) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 05-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced BRONCHITIS (Bronchitis twice), NASOPHARYNGITIS (Four colds) and RHINORRHOEA (Nose has been running constantly). The patient was treated with LORATADINE, PSEUDOEPHEDRINE HYDROCHLORIDE (BENADRYL 24 D) for Adverse event, at an unspecified dose and frequency and OXYMETAZOLINE HYDROCHLORIDE (CLARITIN ALLERGIC) for Adverse event, at an unspecified dose and frequency. At the time of the report, BRONCHITIS (Bronchitis twice), NASOPHARYNGITIS (Four colds) and RHINORRHOEA (Nose has been running constantly) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications were reported.
Age: 43.0
Sex: F
Vaccine: COVID19
Symptoms: Inappropriate schedule of product administration
Clinical narrative: Missed the appointment for second dose; This spontaneous case was reported by a pharmacist and describes the occurrence of INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose) in a 43-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 004C21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose). At the time of the report, INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Missed the appointment for second dose) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medication were reported. No treatment information was reported
Sex: U
Vaccine: COVID19
Symptoms: Vaccination complication
Clinical narrative: Can the vaccine cause a syndrome reaction; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION (Can the vaccine cause a syndrome reaction) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced VACCINATION COMPLICATION (Can the vaccine cause a syndrome reaction). At the time of the report, VACCINATION COMPLICATION (Can the vaccine cause a syndrome reaction) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No Concomitant medication information was provided.  No Treatment medication information was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Asthenia, Diarrhoea, Headache, Illness, Influenza like illness
Clinical narrative: Nausea if she eats too much "had a few teaspoons of oatmeal today"; Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"; Flu like symptoms; I am still sick and very weak; "My head is killing me, it hurts to stand"; 3am Saturday 12Jun2021 I woke up so sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (3am Saturday 12Jun2021 I woke up so sick), DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak) and HEADACHE ("My head is killing me, it hurts to stand") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jun-2021, the patient experienced ILLNESS (3am Saturday 12Jun2021 I woke up so sick), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak) and HEADACHE ("My head is killing me, it hurts to stand"). On 13-Jun-2021, the patient experienced DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"). On 14-Jun-2021, the patient experienced NAUSEA (Nausea if she eats too much "had a few teaspoons of oatmeal today"). At the time of the report, ILLNESS (3am Saturday 12Jun2021 I woke up so sick), DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak), HEADACHE ("My head is killing me, it hurts to stand") and NAUSEA (Nausea if she eats too much "had a few teaspoons of oatmeal today") outcome was unknown.            No concomitant medications were provided.  The patient stated she lives a very healthy lifestyle, was a vegetarian and does not drink or smoke. Patient did not report pre-existing medical conditions.Patient states she received the first and second dose at different vaccine sites.   The patient only had drinking lemonade and grapefruit, soda, crackers, tried not to take any medications.No treatment medication was provided.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Nausea if she eats too much "had a few teaspoons of oatmeal today"; Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"; Flu like symptoms; I am still sick and very weak; "My head is killing me, it hurts to stand"; 3am Saturday 12Jun2021 I woke up so sick; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of ILLNESS (3am Saturday 12Jun2021 I woke up so sick), DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak) and HEADACHE ("My head is killing me, it hurts to stand") in a 66-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 038C21A and 008C21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 04-May-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 12-Jun-2021, the patient experienced ILLNESS (3am Saturday 12Jun2021 I woke up so sick), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak) and HEADACHE ("My head is killing me, it hurts to stand"). On 13-Jun-2021, the patient experienced DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"). On 14-Jun-2021, the patient experienced NAUSEA (Nausea if she eats too much "had a few teaspoons of oatmeal today"). At the time of the report, ILLNESS (3am Saturday 12Jun2021 I woke up so sick), DIARRHOEA (Diarrhea, "can barley make it to the toilet, and I had to change my pants 5 times"), INFLUENZA LIKE ILLNESS (Flu like symptoms), ASTHENIA (I am still sick and very weak), HEADACHE ("My head is killing me, it hurts to stand") and NAUSEA (Nausea if she eats too much "had a few teaspoons of oatmeal today") outcome was unknown.            No concomitant medications were provided.  The patient stated she lives a very healthy lifestyle, was a vegetarian and does not drink or smoke. Patient did not report pre-existing medical conditions.Patient states she received the first and second dose at different vaccine sites.   The patient only had drinking lemonade and grapefruit, soda, crackers, tried not to take any medications.No treatment medication was provided.